(Updated - May 4, 2026 1:15 PM EDT)

Guggenheim analyst Yatin Suneja raised the price target on Axsome Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Axsome Therapeutics (AXSM) PT Raised to $302 at RBC CapitalMay 4, 2026 4:07 PM